Herceptin (Genentech, Inc.)
Welcome to the PulseAid listing for the Herceptin drug offered from Genentech, Inc.. This HER2 Receptor Antagonist [EPC],HER2/Neu/cerbB2 Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Genentech, Inc. |
NON-PROPRIETARY NAME: | Trastuzumab |
SUBSTANCE NAME: | TRASTUZUMAB |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | HER2 Receptor Antagonist [EPC],HER2/Neu/cerbB2 Antagonists [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2017-02-10 |
END MARKETING DATE: | 0000-00-00 |
Herceptin HUMAN PRESCRIPTION DRUG Details:
Item Description | Herceptin from Genentech, Inc. |
LABELER NAME: | Genentech, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 150(mg/7.4mL) |
START MARKETING DATE: | 2017-02-10 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 50242-132_26820703-edfa-4f8a-be67-f8cb08fd681b |
PRODUCT NDC: | 50242-132 |
APPLICATION NUMBER: | BLA103792 |
Other TRASTUZUMAB Pharmaceutical Manufacturers / Labelers: